GlassScriptPhysician profile
Joseph M Majure
NPI 1952450975
$3,127.74
in general payments reported to CMS, 2019-2025
24 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $634 · 2021: $566 · 2022: $494 · 2023: $376 · 2024: $415 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $412.74 | 2019-2023 | Bronchitol |
| Gilead Sciences, INC. | $381.64 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $353.16 | 2020-2023 | |
| Vertex Pharmaceuticals Incorporated | $230.29 | 2019-2025 | |
| Abbvie INC. | $228.92 | 2019-2025 | |
| Baxter Healthcare | $209.20 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Aimmune Therapeutics, INC. | $187.30 | 2024-2025 | Zenpep |
| Advanced Respiratory, INC | $160.59 | 2019-2021 | |
| Philips North America LLC | $153.73 | 2019-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $129.37 | 2021-2024 | |
| Mylan Specialty L.P. | $129.13 | 2019-2024 | Tobi Podhaler |
| Electromed, INC. | $111.87 | 2021-2022 | |
| Vapotherm INC | $94.13 | 2020-2022 | |
| Alcresta Therapeutics, INC. | $93.77 | 2022-2023 | Relizorb |
| Regeneron Healthcare Solutions, INC. | $55.93 | 2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $40.24 | 2025 | Spinraza |
| Digestive Care, INC. | $35.61 | 2023-2024 | Pertzye |
| Genentech USA, INC. | $32.57 | 2022 | |
| Tactile Systems Technology INC | $30.57 | 2024 | Flexitouch Plus, Entre Plus |
| Phadia US INC. | $24.99 | 2019 | |
| Olympus America INC. | $18.19 | 2024 | Single-Use Flexible Video Bronchoscope |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.80 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Majure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.